Exact Mass: 442.27528020000005
Exact Mass Matches: 442.27528020000005
Found 500 metabolites which its exact mass value is equals to given mass value 442.27528020000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cinobufagin
Cinobufagin is a steroid lactone. It is functionally related to a bufanolide. Cinobufagin is a natural product found in Bufo gargarizans, Phrynoidis asper, and other organisms with data available. Cinobufagin is a bufadienolide compound extracted from the dried venom secreted by the parotid glands of toads and one of the glycosides in the traditional Chinese medicine ChanSu, with potential antineoplastic activity. Although the mechanism of action of cinobufagin is still under investigation, it has been found to suppress cancer cell proliferation and cause apoptosis in cancer cells via a sequence of apoptotic modulators that include mitochondrial Bax and cytosolic chromosome c, and caspases 3, 8, and 9. Possible upstream mediators of cinobufagin-induced apoptosis include Fas and p53. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides Annotation level-1 Cinobufagin is an anticancer agent that can be secreted by the Asiatic toad Bufo gargarizans. Cinobufagin induces the cell cycle arrests in the G1 phase or G2/M phase, leading to apoptosis in cancer cells. Cinobufagin inhibits tumor growth in melanoma and glioblastoma multiforme xenograft mouse models[1][2][3]. Cinobufagin is an anticancer agent that can be secreted by the Asiatic toad Bufo gargarizans. Cinobufagin induces the cell cycle arrests in the G1 phase or G2/M phase, leading to apoptosis in cancer cells. Cinobufagin inhibits tumor growth in melanoma and glioblastoma multiforme xenograft mouse models[1][2][3].
Ascorbyl stearate
Ascorbyl stearate is a preservative for margarine Ascorbyl stearate (C24H42O7) is an ester formed from ascorbic acid and stearic acid. In addition to its use as a source of vitamin C, it is used as an antioxidant food additive in margarine (E number E305). The USDA limits its use to 0.02\\% individually or in conjunction with other antioxidants Preservative for margarine
2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea. 2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is a constituent of Tussilago farfara (coltsfoot). Constituent of Tussilago farfara (coltsfoot). 2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea.
Pectachol
Pectachol is found in tea. Pectachol is a constituent of Artemisia abrotanum (southernwood) leaves. Constituent of Artemisia abrotanum (southernwood) leaves. Pectachol is found in tea.
3-O-Acetylepisamarcandin
3-O-Acetylepisamarcandin is found in green vegetables. 3-O-Acetylepisamarcandin is isolated from Ferula assa-foetida (asafoetida Isolated from Ferula assa-foetida (asafoetida). 3-O-Acetylepisamarcandin is found in herbs and spices and green vegetables.
(3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one
(3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one is found in mushrooms. (3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one is a constituent of Hypsizygus marmoreus (bunashimeji) and Pleurotus ostreatus (oyster mushroom)
Muzanzagenin
Muzanzagenin is found in green vegetables. Muzanzagenin is a constituent of the wild asparagus (Asparagus africanus) Constituent of the wild asparagus (Asparagus africanus). Muzanzagenin is found in green vegetables.
Prostaglandin G2 2-glyceryl Ester
Prostaglandin G2 2-glyceryl Ester is also known as 2-Glyceryl-prostaglandin g2. Prostaglandin G2 2-glyceryl Ester is considered to be practically insoluble (in water) and acidic
N-Docosahexaenoyl Asparagine
N-docosahexaenoyl asparagine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Asparagine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Asparagine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Asparagine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
[(2S,4R,5R,6R,14S,16R)-14-Hydroxy-7,11-dimethyl-6-(2-oxopyran-4-yl)-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-5-yl] acetate
Alnespirone
Cinobufagin
Cystone A
DG(2:0/5-iso PGF2VI/0:0)
DG(2:0/5-iso PGF2VI/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/5-iso PGF2VI/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(5-iso PGF2VI/2:0/0:0)
DG(5-iso PGF2VI/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(5-iso PGF2VI/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/5-iso PGF2VI)
DG(2:0/0:0/5-iso PGF2VI) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(5-iso PGF2VI/0:0/2:0)
DG(5-iso PGF2VI/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
9-Hydroxynerolidol-9-O-beta-D-glucopyranoside-2-O-acetate
[1R-(1alpha,2beta,4abeta,5beta,6beta,8aalpha)]-Decahydro-8a-methyl-4-methylene-6-(1-methylethyl)-1,2,5-naphthalenetriol 1,2-diacetate 5-benzoate
14-phenoxytetradecanyl 3,5-dihydroxybenzoate|pistiphloro-glucinyl ester
3alpha-(5-methyldodeca-2E,4E,6E-trienoyloxy)-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one|3alpha-<5-methyldodeca-2E,4E,6E-trienoyloxy>-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one
1beta-acetoxy-9alpha-beta-phenyloxacyclobutanoyloxy-beta-dihydroagarofuran
(2E,6E,10E)-1-(2-hydroxy-5-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-5,12-diol|(2E,6E,10E,14E)-1-(1-hydroxy-4-methoxy-6-methyl phenyl)-5,12-dihydroxy-3,7,11,15-tetramethyl hexadeca-2,6,10,14-tetraene
10-(2,3-dihydro-5-hydroxy-7-methyl-1-benzofuran-2-yl)-10-hydroxy-6-methyl-2-(4-methyl-3-pentenyl)-(2E,6E)-undecadienoic acid|thunbergol B
Ac-12alpha-Hydroxy-24-methyl-24-oxo-16-scalaren-25-al-
(22R,24R)-22,24-epoxy-7,25-dihydroxyergosta-1,4-dien-3-one
(20S,22R)-1alpha,3beta-dihydroxy-witha-5,24-dienolide
22E-3beta-hydroxy-5alpha,6alpha,8alpha,14alpha-diepoxyergost-22-en-7-one
(16beta,22E)-16,18,20-Trihydroxy-24-methylcholesta-1,4,22-trien-3-one
petuniasterone C|petuniasterone C ( (22R,24S)-24,25-epoxy-7alpha,22-dihydroxyergosta-1,4-dien-3-one )
5,7-dihydroxy-4-(1-hydroxypropyl)-6-[(2E)-3,7-dimethyl-2,6-octadienyl]-8-(1-oxobutyl)-2H-benzopyran-2-one|kayeassamin A
3-oxo-21alpha-ethoxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone
(2R)-2,7,8-trimethyl-2-[(3E,7E)-4,8-dimethyl-13-hydroxy-12-hydroxymethyldeca-3,7,11-trienyl]chroman-6-ol|gamma-amplexichromanol
3-hexyl-6-(4-hydroxypentyl)-2H-pyran-2-on-4-O-beta-D-glucopyranoside|whitmanoside A
linalool-beta-D-glucopyranoside-2-O-acetate,6O-isovalerate
linalool-beta-D-glucopyranoside-2O-acetate-6O-<2-methylbutyrate>
(22S,25S)-17alpha,26-dihydroxy-22,25-epoxyfurost-4,6-dien-3-one|diosbulbisin D
22-acetylisocyclocitrinol A|22-O-acetylisocyclocitrinol A
5,7-dihydroxy-4-(1-hydroxypropyl)-6-(1-oxobutyl)-8-[(2E)-3,7-dimethyl-2,6-octadienyl]-2H-benzopyran-2-one|kayeassamin B
5alpha,9alpha-epidioxy-8alpha,14alpha-epoxy-(22E)-ergosta-6,22-dien-3beta-ol|5??,9??-Epidioxy-8??,14??-epoxy-(22E)-ergosta-6,22-dien-3??-ol
(3beta,4beta)-3,4-dihydroxy-24,30-dinoroleana-12,20(29)-dien-28-oic acid|paeonenoide C
6-acetyl-8-t-cinnamyl-1alpha,10beta-epoxyantakyatriol
6-acetyl-8-t-cinnamyl-4beta,5alpha-epoxyantakyatriol
(2E,6E)-5-hydroxy-1-(2-hydroxy-5-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,14-trien-12-one|(2E,6E,14E)-1-(1-hydroxy-4-methoxy-6-methylphenyl)-5-hydroxy-12-one-3,7,11,15-tetramethyl hexadeca-2,6,14-triene|5-hydroxy-12-oxohalidrol
Englerin A
Englerin A is a guaiane sesquiterpenoid that is isolated from the bark of Phyllanthus engleri, a plant native to Tanzania and Zimbabwe. It acts as a potent and specific inhibitor of renal cancer cell growth. It has a role as a metabolite and an antineoplastic agent. It is a guaiane sesquiterpenoid, a cinnamate ester and a glycolate ester. Englerin A is a natural product found in Phyllanthus engleri with data available. A guaiane sesquiterpenoid that is isolated from the bark of Phyllanthus engleri, a plant native to Tanzania and Zimbabwe. It acts as a potent and specific inhibitor of renal cancer cell growth. Englerin A is a potent and selective activator of TRPC4 and TRPC5 channels, with EC50s of 11.2 and 7.6 nM, respectively. Englerin A can induce renal carcinoma cells death by elevated Ca2+ influx and Ca2+ cell overload[1][2][3].
[6-hydroxy-1,1,4a,6-tetramethyl-5-[(2-oxochromen-7-yl)oxymethyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-2-yl] acetate
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid
[6-hydroxy-1,1,4a,6-tetramethyl-5-[(2-oxochromen-7-yl)oxymethyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-2-yl] acetate
C26H34O6_1H-Xanthene-1,3(2H)-dione, 4,9-dihydro-6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methyl-1-oxobutyl)-9-(2-methylpropyl)
C26H34O6_Androsta-11,15-diene-14-carboxylic acid, 3,19-epoxy-15-hydroxy-4,4,8,12,16-pentamethyl-17,19-dioxo-, methyl ester
6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9H-xanthene-1,3-dione
methyl 8-hydroxy-4,5,7,10,14,14-hexamethyl-6,17-dioxo-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-3,7-diene-9-carboxylate
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid [IIN-based on: CCMSLIB00000848208]
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid [IIN-based: Match]
[6-hydroxy-1,1,4a,6-tetramethyl-5-[(2-oxochromen-7-yl)oxymethyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-2-yl] acetate [IIN-based on: CCMSLIB00000845297]
[6-hydroxy-1,1,4a,6-tetramethyl-5-[(2-oxochromen-7-yl)oxymethyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-2-yl] acetate [IIN-based: Match]
Ala Lys Lys Pro
Ala Lys Pro Lys
Ala Lys Pro Gln
Ala Lys Gln Pro
Ala Pro Lys Lys
Ala Pro Lys Gln
Ala Pro Gln Lys
Ala Gln Lys Pro
Ala Gln Pro Lys
Asp Ile Pro Val
Asp Ile Val Pro
Asp Leu Pro Val
Asp Leu Val Pro
Asp Pro Ile Val
Asp Pro Leu Val
Asp Pro Val Ile
Asp Pro Val Leu
Asp Val Ile Pro
Asp Val Leu Pro
Asp Val Pro Ile
Asp Val Pro Leu
Glu Pro Val Val
Glu Val Pro Val
Glu Val Val Pro
Ile Asp Pro Val
Ile Asp Val Pro
Ile Ile Pro Thr
Ile Ile Thr Pro
Ile Ile Val Val
Ile Leu Pro Thr
Ile Leu Thr Pro
Ile Leu Val Val
Ile Pro Asp Val
Ile Pro Ile Thr
Ile Pro Leu Thr
Ile Pro Thr Ile
Ile Pro Thr Leu
Ile Pro Val Asp
Ile Thr Ile Pro
Ile Thr Leu Pro
Ile Thr Pro Ile
Ile Thr Pro Leu
Ile Val Asp Pro
Ile Val Ile Val
Ile Val Leu Val
Ile Val Pro Asp
Ile Val Val Ile
Ile Val Val Leu
Lys Ala Lys Pro
Lys Ala Pro Lys
Lys Ala Pro Gln
Lys Ala Gln Pro
Lys Lys Ala Pro
Lys Lys Pro Ala
Lys Pro Ala Lys
Lys Pro Ala Gln
Lys Pro Lys Ala
Lys Pro Gln Ala
Lys Gln Ala Pro
Lys Gln Pro Ala
Leu Asp Pro Val
Leu Asp Val Pro
Leu Ile Pro Thr
Leu Ile Thr Pro
Leu Ile Val Val
Leu Leu Pro Thr
Leu Leu Thr Pro
Leu Leu Val Val
Leu Pro Asp Val
Leu Pro Ile Thr
Leu Pro Leu Thr
Leu Pro Thr Ile
Leu Pro Thr Leu
Leu Pro Val Asp
Leu Thr Ile Pro
Leu Thr Leu Pro
Leu Thr Pro Ile
Leu Thr Pro Leu
Leu Val Asp Pro
Leu Val Ile Val
Leu Val Leu Val
Leu Val Pro Asp
Leu Val Val Ile
Leu Val Val Leu
Pro Ala Lys Lys
Pro Ala Lys Gln
Pro Ala Gln Lys
Pro Asp Ile Val
Pro Asp Leu Val
Pro Asp Val Ile
Pro Asp Val Leu
Pro Glu Val Val
Pro Ile Asp Val
Pro Ile Ile Thr
Pro Ile Leu Thr
Pro Ile Thr Ile
Pro Ile Thr Leu
Pro Ile Val Asp
Pro Lys Ala Lys
Pro Lys Ala Gln
Pro Lys Lys Ala
Pro Lys Gln Ala
Pro Leu Asp Val
Pro Leu Ile Thr
Pro Leu Leu Thr
Pro Leu Thr Ile
Pro Leu Thr Leu
Pro Leu Val Asp
Pro Gln Ala Lys
Pro Gln Lys Ala
Pro Thr Ile Ile
Pro Thr Ile Leu
Pro Thr Leu Ile
Pro Thr Leu Leu
Pro Val Asp Ile
Pro Val Asp Leu
Pro Val Glu Val
Pro Val Ile Asp
Pro Val Leu Asp
Pro Val Val Glu
Gln Ala Lys Pro
Gln Ala Pro Lys
Gln Lys Ala Pro
Gln Lys Pro Ala
Gln Pro Ala Lys
Gln Pro Lys Ala
Thr Ile Ile Pro
Thr Ile Leu Pro
Thr Ile Pro Ile
Thr Ile Pro Leu
Thr Leu Ile Pro
Thr Leu Leu Pro
Thr Leu Pro Ile
Thr Leu Pro Leu
Thr Pro Ile Ile
Thr Pro Ile Leu
Thr Pro Leu Ile
Thr Pro Leu Leu
Val Asp Ile Pro
Val Asp Leu Pro
Val Asp Pro Ile
Val Asp Pro Leu
Val Glu Pro Val
Val Glu Val Pro
Val Ile Asp Pro
Val Ile Ile Val
Val Ile Leu Val
Val Ile Pro Asp
Val Ile Val Ile
Val Ile Val Leu
Val Leu Asp Pro
Val Leu Ile Val
Val Leu Leu Val
Val Leu Pro Asp
Val Leu Val Ile
Val Leu Val Leu
Val Pro Asp Ile
Val Pro Asp Leu
Val Pro Glu Val
Val Pro Ile Asp
Val Pro Leu Asp
Val Pro Val Glu
Val Val Glu Pro
Val Val Ile Ile
Val Val Ile Leu
Val Val Leu Ile
Val Val Leu Leu
Val Val Pro Glu
(5Z,7E)-(1S,3R,20R,22S)-24a-homo-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R)-18-(4-hydroxy-4-methyl-2-pentynyloxy)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
3-O-Acetylepisamarcandin
Muzanzagenin
4-[(2,5-dioxo-4-Imidazolidinylidene)methyl)-benzaldehyde
2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
Pectachol
Atlantinone A
(22S)-1alpha,22,25-trihydroxy-23,24-tetradehydro-24a-homo-20-epivitamin D3
(2S)-3,4,4,4-tetradeuterio-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-3-(trideuteriomethyl)butanoic acid
C24H22D7N5O3 (442.27096864600003)
Mazipredone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
tert-butyl N-[6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexyl]carbamate
C21H38N4O4S (442.26136280000003)
N,N-Dibenzyl-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane
Dotarizine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
trans,trans-4-(4-Pentyl-bicyclohexyl-4-yl)-3,4,5-trifluorobiphenyl
N-(2-aminoethyl)ethane-1,2-diamine,dimethyl-bis(oxiran-2-ylmethyl)azanium,hexanedioic acid,chloride
(S)-1-((S)-3,3-Dimethyl-2-((S)-2-(methylamino)propanamido)butanoyl)-N-((R)-1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine-2-carboxamide
8-[4-[Propyl(5-methoxychroman-3-yl)amino]butyl]-8-azaspiro[4.5]decane-7,9-dione
2-[(9-tert-butyl-1,5-dicyano-2-oxo-3-azaspiro[5.5]undec-4-en-4-yl)thio]-N-cyclohexylacetamide
(3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one
(2E,6E,10E)-1-(2,5-dihydroxy-3-methylphenyl)-13-(3,3-dimethyloxiran-2-yl)-12-hydroxy-3,7,11-trimethyltrideca-2,6,10-trien-5-one
3alpha,7alpha-Dihydroxy-5beta-cholane-24-sulfonic acid
C24H42O5S (442.27528020000005)
2-(1-adamantyl)-N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]acetamide
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid
1-[[(2S,3S)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2R,3R)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2R,3R)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2R,3S)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2S,3S)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2S,3R)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2R,3S)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
N-[(2S,3R)-4-[1,3-benzodioxol-5-ylmethyl(methyl)amino]-3-methoxy-2-methylbutyl]-N-[(2R)-1-hydroxypropan-2-yl]benzamide
C25H34N2O5 (442.24675940000003)
N-[2-[1-[2-(7-quinolinyloxy)ethyl]-2-benzimidazolyl]ethyl]cyclohexanecarboxamide
C27H30N4O2 (442.23686399999997)
N-[(2S,3S)-4-[1,3-benzodioxol-5-ylmethyl(methyl)amino]-3-methoxy-2-methylbutyl]-N-[(2S)-1-hydroxypropan-2-yl]benzamide
C25H34N2O5 (442.24675940000003)
1-[[(2S,3R)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
N-[(1S,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H34N2O5 (442.24675940000003)
N-[(1S,3S,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H34N2O5 (442.24675940000003)
N-[(2R,3S)-4-[1,3-benzodioxol-5-ylmethyl(methyl)amino]-3-methoxy-2-methylbutyl]-N-[(2R)-1-hydroxypropan-2-yl]benzamide
C25H34N2O5 (442.24675940000003)
N-[(2S,3S)-4-[1,3-benzodioxol-5-ylmethyl(methyl)amino]-3-methoxy-2-methylbutyl]-N-[(2R)-1-hydroxypropan-2-yl]benzamide
C25H34N2O5 (442.24675940000003)
N-[(1R,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H34N2O5 (442.24675940000003)
N-[(1R,3S,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H34N2O5 (442.24675940000003)
N-[(1S,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H34N2O5 (442.24675940000003)
N-[(1R,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H34N2O5 (442.24675940000003)
N-[(1R,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H34N2O5 (442.24675940000003)
N-[(1S,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H34N2O5 (442.24675940000003)
N-[(2S,3R)-4-[1,3-benzodioxol-5-ylmethyl(methyl)amino]-3-methoxy-2-methylbutyl]-N-[(2S)-1-hydroxypropan-2-yl]benzamide
C25H34N2O5 (442.24675940000003)
N-[(2R,3R)-4-[1,3-benzodioxol-5-ylmethyl(methyl)amino]-3-methoxy-2-methylbutyl]-N-[(2S)-1-hydroxypropan-2-yl]benzamide
C25H34N2O5 (442.24675940000003)
N-[(2R,3S)-4-[1,3-benzodioxol-5-ylmethyl(methyl)amino]-3-methoxy-2-methylbutyl]-N-[(2S)-1-hydroxypropan-2-yl]benzamide
C25H34N2O5 (442.24675940000003)
N-[(2R,3R)-4-[1,3-benzodioxol-5-ylmethyl(methyl)amino]-3-methoxy-2-methylbutyl]-N-[(2R)-1-hydroxypropan-2-yl]benzamide
C25H34N2O5 (442.24675940000003)
1-[3-methyl-2-[2-(methylamino)propanoylamino]pentanoyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine-2-carboxamide
2,3-Dihydroxypropyl (2-hydroxy-3-tetradecoxypropyl) hydrogen phosphate
(5R,6S,9S,11R,13S,15S,16S,17R,19S,21S)-6,21-dimethyl-21-(4-methyl-3-methylidenepentyl)-14,18,20-trioxaheptacyclo[15.4.1.02,16.02,19.05,15.06,11.013,15]docosan-9-ol
Prostaglandin G2 2-glyceryl Ester
A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin G2 with the 2-hydroxy group of glycerol.
trichloro(docosyl)silane
An organosilicon compound that is docosylsilane in which the hydrogens attached to the Si atom have been replaced by chloro groups. Metabolite observed in cancer metabolism.